At the early stages of hepatic fibrosis, less ECM deposition might end up with weak YAP activation, while more ECM deposition at the later stages of fibrosis might lead to strong YAP activation accelerating the rate of ECM deposition and exacerbate the disease progression. This evidence concerns the gene YAP1 and Hepatic fibrosis.